Latest news
Cellular therapy in ALS: what's next after face I and II clinical trials? - Faculty of Psychology - Facultats - UB - Universitat de BarcelonaUB - Universitat de Barcelona · Mon, 10 Aug 2026 17:56:44 GMTImpressive top-line Phase II results for AbCellera’s ABCL635 - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 16:06:51 GMTFirst patient dosed with AK146D1 in Akeso’s Phase II study - Clinical Trials ArenaClinical Trials Arena · Mon, 10 Aug 2026 13:34:39 GMTAbCellera’s ABCL-635 Cuts Menopause Hot Flashes 83% in Phase II Trial - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:03:44 GMTArtelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 13:03:06 GMTArtelo Tests an Oral Cannabinoid for Glaucoma Eye Pressure - Stock TitanStock Titan · Mon, 10 Aug 2026 12:47:00 GMTSilence brings the noise to Takeda with phase 2 blood cancer win - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 11:31:00 GMTAbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile - MorningstarMorningstar · Mon, 10 Aug 2026 11:00:00 GMT